Targeting the BRAF pathway in haematological diseases
Internal Medicine Journal · 2023
DOI: 10.1111/imj.16091 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Internal Medicine Journal, 2023. Verfasst von Matthew J Rees und 7 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins B-raf, Hematologic Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Abstract (Originalsprache)
Since the recognition of BRAF V600E mutations in the majority of cases of hairy cell leukaemia, Erdheim–Chester disease and Langerhans cell histiocytosis, the targeted oral kinase inhibitors dabrafenib and vemurafenib have been adapted for their treatment. Like other targeted agents, these drugs produce high response rates and predictable but unique side effects. Physician familiarity is essential for the effective use of these agents. We review the Australian experience of BRAF/MEK inhibitor therapy in these rare haematological cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Victoria, Australia.
- Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.
- Department of Clinical Haematology, St Vincent's Hospital, Sydney, New South Wales, Australia.
- Department of Clinical Haematology, Gold Coast University Hospital, Gold Coast, Queensland, Australia.
- Department of Clinical Haematology, Austin Health, Melbourne, Victoria, Australia.
ORCID-Profile: Matthew J Rees, Michael Dickinson
Zitieren
APA
Rees, M. J., Dickinson, M., Paterson, J., Ng, T. F., Grigg, A., Moore, J., Blombery, P., & Seymour, J. F. (2023). Targeting the BRAF pathway in haematological diseases. Internal Medicine Journal. https://doi.org/10.1111/imj.16091
Vancouver
Rees MJ, Dickinson M, Paterson J, Ng TF, Grigg A, Moore J, et al. Targeting the BRAF pathway in haematological diseases. Internal Medicine Journal. 2023. doi:10.1111/imj.16091
BibTeX
@article{Rees2023,
author = {Rees, Matthew J and Dickinson, Michael and Paterson, James and Ng, Teng F and Grigg, Andrew and Moore, John and Blombery, Piers and Seymour, John F},
title = {Targeting the BRAF pathway in haematological diseases},
journal = {Internal Medicine Journal},
year = {2023},
doi = {10.1111/imj.16091}
}
EUVIMED